Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
10,208,000
Publication Date
2-19-2019
Abstract
Provided herein are novel small-molecules that have use in the inhibition of Eis, which mediates kanamycin resistance in Mycobacterium tuberculosis. The presently-disclosed subject matter further includes a pharmaceutical composition including a small molecule inhibitor, as described herein, and a suitable pharmaceutical carrier. Methods of treating tuberculosis comprising administering to an individual an effective amount of the disclosed small molecule inhibitors to mediate kanamycin A resistance and treat tuberculosis are also provided.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US), The United States of America, as represented by the Secretary, Department of Health and Human Services, Rockville, MD (US)
Application Number
15/381,901
Filing Date
12/16/2016
Recommended Citation
Garneau-Tsodikova, Sylvie; Tsodikov, Oleg V.; and Posey, James E., "Eis Inhibitors" (2019). Pharmaceutical Sciences Faculty Patents. 180.
https://uknowledge.uky.edu/ps_patents/180
